期刊文献+

环氧化酶2/前列腺素E_2在血管紧张素Ⅱ刺激巨噬细胞表达细胞外基质金属蛋白酶诱导因子中的作用 被引量:1

Effect of Angiotensin Ⅱ on Extracellular Matrix Metalloproteinase Inducer Expression in Macrophages via AT_1R/COX-2/PGE_2 Pathway
原文传递
导出
摘要 目的了解血管紧张素Ⅱ(AngⅡ)在动脉粥样硬化不稳定斑块中的作用及其相关信号传导通路,探讨AngⅡ对人单核细胞株(THP-1)巨噬细胞表达细胞外基质金属蛋白酶诱导因子(EMMPRIN)中的作用及其机制。方法以浓度为5μg/L的佛波醇诱导THP-1成巨噬细胞后,用浓度为10-6mol/L AngⅡ刺激巨噬细胞。RT-PCR及Western blot测AngⅡ刺激后的巨噬细胞中EMMPRIN基因及蛋白的表达,用ELISA监测刺激后上清中的前列腺素E2(PGE2)的变化。为进一步研究其具体机制,分别用血管紧张素1型受体(AT1R)拮抗剂(10-5mol/L)、血管紧张素2型受体(AT2R)拮抗剂(10-5mol/L)、环氧化酶2(COX-2)抑制剂(10-5mol/L)及PGE2(10-7mol/L)探讨其信号传导机制。结果AngⅡ可明显诱导巨噬细胞内的EMMPRIN基因及蛋白的表达,刺激后6 h可见明显增加,12 h达到最高,24 h后下降。相比于对照组(RPMI-1640培养基组),AngⅡ刺激12 h后基因表达量约增加至5倍,蛋白的表达约增加至4倍,而在AngⅡ刺激后引起的COX-2、PGE2与EMMPRIN的蛋白改变基本一致。进一步的信号通路研究实验结果显示AT1R拮抗剂及COX-2抑制剂可明显降低AngⅡ的诱导作用,再加入PGE2这种抑制作用可被反转,而AT2R拮抗剂则无影响。结论在佛波醇诱导后的THP-1巨噬细胞中,AngⅡ可通过AT1R/COX-2/PGE2途径上调巨噬细胞中EMMPRIN的表达,而AT2R则无影响。 Objective To explore the expression of extracellular matrix metalloproteinase inducer (EMMPRIN) in human leukemic cell line (THP-1) macrophages produced by angiotensin Ⅱ [AngⅡ ) stimulation and its possible mechanisms. Methods THP-1 monocyte were cultured with 5μg/L PMA and transformed into macrophages by 10^6 mol/L Ang Ⅱ. EMMPRIN gene and its protein were measured by real-time PCR and Western blot. PGE2 expression was assayed by ELISA angiotensin type 1 receptor (AT1R, 10^-5mol/L)antagonist, angiotensin type 2 receptor ( AT2 R, 10-5 mol/L) antagonist, eyclooxygenase-2 ( COX-2 ) inhibitor, NS-398, were used to inhibit the effect of AngⅡ , and prostaglandin E2 (PGE2) was added to delineate the mechanism of Ang Ⅱ -induced EMMPRIN expression. Results Ang Ⅱ induced the EMMPRIN expression obviously in macrophages, enhanced at 6 h, peaked at 12 h and declined after 24 h. Compared to the control group (RPMI-1640 group), gene expres- sion of EMMPRIN was increased to 5 times by Ang Ⅱ (10^6 mol/L) stimulation after 12 h; protein expression was increased to 4 times. In addition, the tendency of enhancement of COX-2 and PGE2 by Ang Ⅱ stimulation were coincident with the expression of EMMPRIN. AT1R antagonist and COX-2 inhibitor, but not AT2R antagonist, PD123319 inhibited the effect of Ang Ⅱ. Conclusion Ang Ⅱ up-regulate the EMMPRIN expression in THP-1 macrophages via AT1R/COX-2/PGE2 signal transduction pathway.
出处 《中华高血压杂志》 CAS CSCD 北大核心 2009年第10期906-911,共6页 Chinese Journal of Hypertension
基金 云南省社会发展科技计划(2008C150M)
关键词 血管紧张素Ⅱ 巨噬细胞 细胞外基质金属蛋白酶诱导因子 环氧化酶2 前列腺素E2 Angiotensin Ⅱ Macrophage Extracellular matrix metalloproteinase inducer Cyclooxygenase-2 Prostaglandin E2
  • 相关文献

参考文献25

  • 1Kanekura T, Chen X, Kanzaki T. Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts[J]. Int J Cancer, 2002,99:520-528.
  • 2Major TC, Liang L, Lu X,et al. Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma [J]. Arterioscler Thromb Vasc Biol, 2002,22 : 1200 -1207.
  • 3Yoon YW, Kwon HM, Hwang KC, et al. Upstream regulation of matrix metalloproteinase by EMMPRIN, extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque[J]. Atherosclerosis, 2005,180 : 37-44.
  • 4叶金善,郭瑞威,杨丽霞.细胞外基质金属蛋白酶诱导因子与急性冠脉综合征关系的研究进展[J].心血管病学进展,2009,30(1):182-184. 被引量:3
  • 5Cipollone F, Fazia M, Iezzi A, et al. Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity[J]. Circulation, 2004,109 : 1482-1488.
  • 6Park EK, Jung HS, Yang HI, et al. Optimized THP 1 differentiation is required for the detection of responses to weak stimuli[J]. Inflamm Res, 2007,56 : 45- 50.
  • 7Eldika N, Yerra L, Chi DS, et at. Atherosclerosis as an inflammatory disease: implications for therapy[J]. Front Biosci, 2004,9: 2764-2777.
  • 8McEver RP. Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation[J]. Thromb Haemost, 2001,86 : 746-756.
  • 9Koki A, Khan NK, Woerner BM, et al. Cyclooxygenase 2 in human pathological disease[J]. Adv Exp Med Biol, 2002,507: 177- 184.
  • 10Burleigh ME, Babaev VR, Yaneey PG, et al. Cyclooxygenase-2 promotes early atherosclerotie lesion formation in ApoE-deficient and C57BL/6 mice[J]. J Mol Cell Cardiol, 2005,39 : 443-452.

二级参考文献40

  • 1Decastro R, Zhang Y, Guo H, et al. Human keratinocytes express EMMPRIN, an extracellular matrix metalloproteinase inducer [ J ]. J Invest Dermatol, 1996, 106 (6) :1260-1265.
  • 2Kanekura T, Chen X, Kanzaki T. Basigin ( CD147 ) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts [ J ]. Intern J Cancer,2002,99 (4) :520-528.
  • 3Menashi S, Sereva M, Ma L,et al. Regulation of extracellular matrix metalloproteinase expression by amphiregulin in transformed human breast epithelial cells [ J ]. Cancer Res,2003,63 ( 22 ) :7575-7580.
  • 4Major TC, Liang L. Lu X, et al. Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma[ J]. Arterioscler Thromb Vasc Biol,2002,22(7):1200-1207.
  • 5Virmani R, Burke AP, Farb A, et al. Pathology of the vulnerable plaque [ J ]. J Am Coll Cardiol,2006,47 ( 8 suppl) : C13-18.
  • 6Schmidt R, Bultmann A, Ungerer M,et al. Extracellular matrix metallopmteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells : implications in acute myocardial infarction [ J ]. Circulation,2006,113 (6) :834 -841.
  • 7Galis ZS,Surhova GR, Lark MW, et al. Increased expression of matrix metalloproteinases and matrix degraded activity in vulnerable regions of human atherosclerotic plaques[ J]. J Clin Invest, 1994,94:2493-2503.
  • 8Sluijter JP, Pulskens WP, Schaneveld AH, et al. Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions[ J]. Stroke,2006,37 ( 1 ) :235-239.
  • 9Ikeda U, Shimada K. Matrix metalloproteinases and coronary artery diseases [ J]. Clin Cardiol,2003,26(2) :55-59.
  • 10Zhang JF, Ge H. Inhibitory effect of PPAR on the expression of EMMPRIN in macrophages and foam cells [ J ]. Intern J Cardiol,2007,117 ( 3 ) :373-380.

共引文献6

同被引文献14

  • 1Virmani R, Burke AP, Farb A. Pathology of the vulnerable plaque [ J ]. JAm Coll Cardiol, 2006, 47 (6) : c13-18.
  • 2Browatzki M, LarsenD, Pfeiffer CA. Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor- KB and activator protein 1 in a redox-sensitive manner [ J ]. J Vasc Res, 2005, 42 (5): 415-423.
  • 3Yoon YW, Kwon HM, Hwang KC, et al. Upstream regulation of matrix metalloproteinase by EMMPRIN; extracellular matrix metalloproteinase inducer in advancedatherosclerotic plaque [ J]. Atherosclerosis , 2005, 180 (1): 37-44.
  • 4Guo RW, Yang LX, Wang H. Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells [ J ]. Regul Pept, 2008, 147 ( 1-3 ) : 37-44.
  • 5Rosenfeld ME, Polinsky P, Virmani R, et al. Advanced atherosclerotic lesions in the innominate artery of the apoe knockout mouse [ J ]. Arterioscler Thromb Vasc Biol, 2000, 20 (12): 2 587-592.
  • 6Johnson JL, Jackson CL. Atherosclerotic plaque rupture in the apolipoprotein E knockout Mouse [J]. Atherosclerosis, 2001, 154 (2) : 399-406.
  • 7Newby AC. Metalloproteinase expression in monocytes and maerophages and its relationship to atherosclerotic plaque instability [ J ]. Arterioscler Thromb Vasc Biol, 2008, 28 (12): 2 108-114.
  • 8Koenig W, Khuseyinova N. Biomarkers of atherosclerotic plaque instability and rupture [ J ]. Arterioscler Thromb Vasc Biol, 2007, 27 ( 1 ) : 15- 26.
  • 9Lucia M, Duchosal MA, Korber M. Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-/- mice [ J]. Hypertension, 2004, 44 (3) : 277-282.
  • 10Iacono KT, Brown AL, Greene MI, et al. CDI47 immunoglobulin superfamily receptor function and role in pathology [ J ]. Exp Mol Pathol, 2007, 83 (3) : 283-295.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部